21178099

Source:http://linkedlifedata.com/resource/pubmed/id/21178099

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013264, umls-concept:C0017431, umls-concept:C0521117, umls-concept:C1420369, umls-concept:C1521761
pubmed:issue	3
pubmed:dateCreated	2011-1-18
pubmed:abstractText	Duchenne muscular dystrophy (DMD) is the most common single-gene lethal disorder. Substantial patient-patient variability in disease onset and progression and response to glucocorticoids is seen, suggesting genetic or environmental modifiers.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1U54HD053177, http://linkedlifedata.com/resource/pubmed/grant/5R24HD050846
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21178099-21178098
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids, http://linkedlifedata.com/resource/pubmed/chemical/Osteopontin, http://linkedlifedata.com/resource/pubmed/chemical/SPP1 protein, human
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1526-632X
pubmed:author	pubmed-author:AngeliniCC, pubmed-author:BelluRR, pubmed-author:BonifatiM DMD, pubmed-author:CagninSS, pubmed-author:Cooperative International Neuromuscular Research Group, pubmed-author:DevaneyJ MJM, pubmed-author:ErmaniMM, pubmed-author:GavassiniB FBF, pubmed-author:Gordish-DressmanHH, pubmed-author:HoffmanE PEP, pubmed-author:KesariAA, pubmed-author:LanfranchiGG, pubmed-author:LeeII, pubmed-author:McDonaldC MCM, pubmed-author:PacchioniBB, pubmed-author:PegoraroEE, pubmed-author:PivaLL, pubmed-author:SoraruGG
pubmed:issnType	Electronic
pubmed:day	18
pubmed:volume	76
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	219-26
pubmed:dateRevised	2011-3-14
pubmed:meshHeading	pubmed-meshheading:21178099-Child, pubmed-meshheading:21178099-Child, Preschool, pubmed-meshheading:21178099-Cross-Sectional Studies, pubmed-meshheading:21178099-Disease Progression, pubmed-meshheading:21178099-Female, pubmed-meshheading:21178099-Genotype, pubmed-meshheading:21178099-Glucocorticoids, pubmed-meshheading:21178099-Humans, pubmed-meshheading:21178099-International Cooperation, pubmed-meshheading:21178099-Italy, pubmed-meshheading:21178099-Kaplan-Meier Estimate, pubmed-meshheading:21178099-Male, pubmed-meshheading:21178099-Muscular Dystrophy, Duchenne, pubmed-meshheading:21178099-Odds Ratio, pubmed-meshheading:21178099-Osteopontin, pubmed-meshheading:21178099-Polymorphism, Single Nucleotide, pubmed-meshheading:21178099-Predictive Value of Tests, pubmed-meshheading:21178099-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:21178099-Severity of Illness Index
pubmed:year	2011
pubmed:articleTitle	SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy.
pubmed:affiliation	Neuromuscular Center, Department of Neurosciences, University of Padova, 35128 Padova, Italy elena.pegoraro@unipd.it.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural